| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.49▲ | 5.49▲ | 5.49▲ | 5.55▼ | 4.94▲ |
| MA10 | 5.50▲ | 5.50▲ | 5.50▲ | 5.37▲ | 4.55▲ |
| MA20 | 5.48▲ | 5.46▲ | 5.38▲ | 5.05▲ | 4.17▲ |
| MA50 | 5.34▲ | 5.19▲ | 5.02▲ | 4.61▲ | 4.08▲ |
| MA100 | 5.05▲ | 4.76▲ | 4.72▲ | 4.15▲ | 3.56▲ |
| MA200 | 4.76▲ | 4.48▲ | 4.29▲ | 3.92▲ | 3.15▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | -0.015▼ | -0.009▼ | 0.027▲ | 0.151▲ |
| RSI | 58.612▲ | 63.311▲ | 64.192▲ | 60.209▲ | 67.098▲ |
| STOCH | 47.394 | 56.377 | 58.266 | 67.138 | 60.007 |
| WILL %R | -11.364▲ | -11.364▲ | -9.259▲ | -42.318 | -19.321▲ |
| CCI | 85.198 | 96.649 | 99.574 | 50.166 | 157.255▲ |
|
Tuesday, July 07, 2026 04:17 AM
Official FDA minutes confirm the previously announced End-of-Phase 2 meeting outcomes and provide additional detail on the planned Phase 3 protocol — – FDA agreed that a single pivotal Phase 3 trial ...
|
|
Tuesday, April 21, 2026 05:00 PM
MELBOURNE, Australia and SAN FRANCISCO, April 22, 2026 (GLOBE NEWSWIRE)-- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing ...
|
|
Wednesday, December 17, 2025 04:09 PM
Fintel reports that on December 17, 2025, Canaccord Genuity initiated coverage of Alterity Therapeutics Limited - Depositary Receipt (NasdaqCM:ATHE) with a Speculative Buy recommendation. There are 17 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/07/26 | 5.47 | 5.545 | 5.38 | 5.43 | 5,576 |
| 09/07/26 | 5.18 | 5.5899 | 5.18 | 5.38 | 25,071 |
| 08/07/26 | 5.62 | 5.70 | 5.3302 | 5.58 | 6,281 |
| 07/07/26 | 5.76 | 5.76 | 5.4001 | 5.49 | 18,558 |
| 06/07/26 | 5.49 | 5.8922 | 5.49 | 5.89 | 17,506 |
| 02/07/26 | 5.56 | 5.59 | 5.16 | 5.36 | 19,463 |
| 01/07/26 | 5.42 | 5.58 | 5.41 | 5.46 | 34,431 |
| 30/06/26 | 4.90 | 5.745 | 4.90 | 5.37 | 88,719 |
| 29/06/26 | 4.885 | 4.92 | 4.84 | 4.89 | 19,315 |
| 26/06/26 | 4.90 | 4.95 | 4.80 | 4.82 | 23,383 |
|
|
||||
|
|
||||
|
|